←Back to Expert Scholars
Translational Medicine / 转化医学Cancer Metabolism Milestones, Hexokinase II
Peter Pedersen
PhD
🏢Johns Hopkins University School of Medicine🌐USA
Emeritus Professor of Biological Chemistry
95
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Peter Pedersen revived modern interest in the Warburg effect through work on hexokinase II and mitochondrial-bound glycolysis. His group developed 3-bromopyruvate as a candidate metabolic anticancer agent. He has been a long-standing voice for cancer bioenergetics research.
Share:
🧪Research Fields 研究领域
hexokinase II
mitochondrial bound glycolysis
Warburg effect revival
3-bromopyruvate
cancer bioenergetics
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Peter Pedersen 的研究动态
Follow Peter Pedersen's research updates
留下邮箱，当我们发布与 Peter Pedersen（Johns Hopkins University School of Medicine）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment